Researchers at University Medical Center Mannheim Target Antituberculosis Agents (Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance)

MLA

“Researchers at University Medical Center Mannheim Target Antituberculosis Agents (Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance).” Obesity, Fitness & Wellness Week, Oct. 2021, p. 4744. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.678541552&authtype=sso&custid=ns315887.

APA

Researchers at University Medical Center Mannheim Target Antituberculosis Agents (Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance). (2021, October 16). Obesity, Fitness & Wellness Week, 4744.

Chicago

Obesity, Fitness & Wellness Week. 2021. “Researchers at University Medical Center Mannheim Target Antituberculosis Agents (Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance),” October 16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.678541552&authtype=sso&custid=ns315887.